Exicure, Inc. is the pioneer in gene regulatory and immunotherapeutic drugs utilizing three-dimensional SNA.
Skokie, IL
Joined December 2016
- Tweets231
- Following549
- Followers435
- Likes50
Exicure today reported financial results for the quarter ended June 30, 2022 and provided an update on its business strategy and corporate progress: bit.ly/3SRryaw
Exicure remains proudly dedicated to discovering treatments for those affected by #HuntingtonsDisease. Together, we can break down stigmas, and work to bring hope to those living with HD and their families. #HDAwarenessMonth
Today is International #HuntingtonsDisease Awareness Day, so #LetsTalkAboutHD! To learn more about #HD & the #HDSAFamily please visit HDSA.org.
Exicure today announced a poster presentation at #TIDESUSA 2022, May 9-12, 2022: bit.ly/3slI72S
Today we celebrated our team with an appreciation breakfast 🍳 Thank you to every Exicurian for your hard work and talent! #EmployeeAppreciationDay
Exicure today reported financial results for the third quarter 2021 and provided an update on corporate progress: bit.ly/3CxOrX8
Exicure today announced presentations at TIDES EU and Neuroscience 2021: bit.ly/3EoP1aT #DigitalDrugDesign #SfN21
Interested in joining a team of dedicated scientists who are developing nucleic acid-based therapeutics to treat rare and severe genetic diseases and cancers? Exicure is #hiring! To learn more about our open positions, visit: bit.ly/3v6x25Q
A special thank you from the Exicure team to @CureFA_org for the invitation to present at this weekend’s Friedreich’s Ataxia Patient Symposium, a very important event in raising awareness & support to aid in the advancement of medical breakthroughs for #FA patients globally.
Check out this @sciam OpEd by Exicure Co-founder @CHADNANO about the successes in #nanotechnology and #nanochemistry research over the past two decades. #DigitalDrugDesign
"There is a beautifully simple principle at the heart of modern nanotechnology research. Bulk materials become brand-new when miniaturized or restructured at the nanoscale." | Commentary scientificamerican.com/artic…
We loved getting together for our quarterly Exicure Town Hall today! To learn more about our team, visit bit.ly/3uOpjsS.
Exicure today announced presentations at the 17th International Congress on Neuronal Ceroid Lipofuscinosis (NCLs) and the International OligonucIeotides and Peptides Conference (IOPC) 2021: bit.ly/3AiJU9R #DigitalDrugDesign
The Exicure team proudly sported blue and red in support of the initiatives by @Cure_FA and @NAF_Ataxia in raising awareness of #friedreichsataxia.
Exicure retweeted
Ataxia is a rare disease with symptoms that worsen over time making it hard to walk, talk and coordinate movement. Learn more: ataxia.org - Share our post to help others learn about Ataxia. #IAAD21
Exicure CEO @giljohann will present at the Benzinga Healthcare #SmallCap Conference on September 30, 2021, at 3:20 PM ET: bit.ly/3o1kzyE
Connect with the healthcare Small Cap audience LIVE on Sept 29 and 30. Learn about small cap investing with clearly defined education sessions from professional educators, see exclusive CEO interviews, & more. You don’t want to miss this hubs.ly/H0Xq4XR0 #smallcap
Exicure today announced participation in TIDES USA 2021 and the 17th Annual Meeting of the Oligonucleotide Therapeutics Society: bit.ly/39731bV #OTS #DigitalDrugDesign
Exicure retweeted
Dear Lawmakers @POTUS @RonWyden @SpeakerPelosi Hundreds of us biotech investors, innovators, patient advocates, & NIH academics representing >40k US jobs, >600 drugs in trials, & >$200B invested propose solutions to affordability that preserve R&D. 1/
nopatientleftbehind.docsend.…
Exicure today reported financial results for the quarter ended June 30, 2021 and provided an update on corporate progress: bit.ly/3jHx3ry #DigitalDrugDesign
Exicure CEO @giljohann will present at the BTIG Virtual Biotechnology Conference on Monday, August 9, 2021 at 2:30pm ET: bit.ly/3ytTjeE
